Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesSentinel Lymph Node Biopsy for Melanoma: Indications and Rationale
Cancer Control, 06/30/09
Phan GQ et al. - SLNB provides important prognostic and staging data with minimal morbidity and can be used to identify regional node-negative patients who would not benefit from a complete nodal dissection. In the authors opinion, SLNB should be performed on most patients (with acceptable surgical and anesthesia risk) who have melanomas with a Breslow depth >= 0.76 mm.
Jonathan S. Zager and Giao Phan, 06/30/09
| This article adds to the growing body of literature that supports the use of sentinel node biopsy for melanomas. The SLNB is a staging technique that allows for identification of patients who will (or will not) need more surgery and adjuvant therapy. It has been proven to be the single most independant prognostic factor in terms of overall survival in melanoma patients (Gershenwald JCO 2001). Ongoing trials such as the Multicenter Selective Lymphadenectomy Trial II will hopefully determine those patients with positive sentinel nodes who are at risk for further nodal metastases based on primary tumor properties and SLN burden of disease. It is our opinion that this staging method is safe with limited morbidity and adds important prognostic information for clinicians in treating patients with melanoma and should be used for all aptients who are good surgical candidates with melanomas greater than 0.75 mm thick. |
Related Articles
Loss of SNF5 expression correlates with poor patient survival in melanoma
Clinical Cancer Research, 10/12/09
Relevance Score: 97%
Slow-growing melanoma: a dermoscopy follow-up study
British Journal of Dermatology, 10/05/09
Relevance Score: 93%
Dormancy of metastatic melanoma
Pigment Cell & Melanoma Research, 11/11/09
Relevance Score: 91%
ADAM10 Is Upregulated in Melanoma Metastasis Compared with Primary Melanoma
Journal of Investigative Dermatology, 11/03/09
Relevance Score: 91%
KIT as a Therapeutic Target in Melanoma
Journal of Investigative Dermatology, 10/23/09
Relevance Score: 90%
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanoma
International Journal of Cancer, 12/07/09
Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion
International Journal of Cancer, 12/07/09
Functional implication of Netrin expression in malignant melanoma
Cellular Oncology, 12/07/09
Today in Diagnostics/Radiology...keeping you current
Receive free subspecialty "5-minute updates" via email
The use of an immunohistochemical diagnostic panel to determine the primary site of cervical lymph node metastases of occult squamous cell carcinoma
Human Pathology, 12/07/09
PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma
Human Pathology, 12/07/09
Papillary squamous intraepithelial lesions of the uterine cervix: human papillomavirus-dependent changes in cell cycle expression and cytologic features
Human Pathology, 12/07/09
Sponsor
Article Search
Sponsor
Sponsor